MCM
RCKT icon

Manchester Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Manchester Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-100
Closed -$1K – 508
2017
Q3 		$1K Hold
100
– – ﹤0.01% 476
2017
Q2 		$1K Hold
100
– – ﹤0.01% 478
2017
Q1 		$1K Hold
100
– – ﹤0.01% 493
2016
Q4 		$2K Hold
100
– – ﹤0.01% 488
2016
Q3 		$4K Hold
100
– – ﹤0.01% 484
2016
Q2 		$3K Hold
100
– – ﹤0.01% 508
2016
Q1 		$3K Hold
100
– – ﹤0.01% 566
2015
Q4 		$5K Hold
100
– – ﹤0.01% 628
2015
Q3 		$4K Buy
+100
New +$4.59K ﹤0.01% 605

Other funds holding RCKT

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GTC
Ghost Tree Capital New York $276M AUM 70.11% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return